External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients
SCORE2 underestimated CVD risk in cancer patients. After recalibration, the model may serve as a valuable tool for risk stratification in cancer patients.
Authors
- Håvard Dalen (ORCID: https://orcid.org/0000-0003-1192-3663)
- Mari Nordbø Gynnild (ORCID: https://orcid.org/0000-0001-8623-7911)
- Steven H J Hageman (ORCID: https://orcid.org/0000-0003-2299-6745)
- Espen Holte (ORCID: https://orcid.org/0000-0002-8891-1372)
- Torbjørn Omland (ORCID: https://orcid.org/0000-0002-6452-0369)
- Jannick A N Dorresteijn (ORCID: https://orcid.org/0000-0002-0190-8526)
- Joris Holtrop (ORCID: https://orcid.org/0009-0005-7616-3839)
- Frank L.J. Visseren (ORCID: https://orcid.org/0000-0003-3951-5223)
- Torgeir Wethal (ORCID: https://orcid.org/0000-0003-0201-3342)
- Victoria Vinje
Institutions
- University of Oslo (NO)
- Norwegian University of Science and Technology (NO)
- Akershus University Hospital (NO)
- Levanger Hospital (NO)
- University Medical Center Utrecht (NL)
- St Olav's University Hospital (NO)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1093/eurjpc/zwaf356
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Norges Teknisk-Naturvitenskapelige Universitet
- Roy A. Hunt Foundation
- Helse Midt-Norge
- Faculty of Medicine and Health, University of Sydney
- Norwegian Institute of Public Health